Logo image of MGLD

MARYGOLD COMPANIES INC/THE (MGLD) Stock Fundamental Analysis

NYSEARCA:MGLD - NYSE Arca - US57403M1045 - Common Stock - Currency: USD

0.9722  -0.03 (-2.78%)

Fundamental Rating

3

Taking everything into account, MGLD scores 3 out of 10 in our fundamental rating. MGLD was compared to 225 industry peers in the Capital Markets industry. MGLD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MGLD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MGLD had negative earnings in the past year.
MGLD had a negative operating cash flow in the past year.
Of the past 5 years MGLD 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: MGLD reported negative operating cash flow in multiple years.
MGLD Yearly Net Income VS EBIT VS OCF VS FCFMGLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

With a Return On Assets value of -12.37%, MGLD is not doing good in the industry: 89.04% of the companies in the same industry are doing better.
MGLD has a Return On Equity of -15.29%. This is amonst the worse of the industry: MGLD underperforms 84.02% of its industry peers.
Industry RankSector Rank
ROA -12.37%
ROE -15.29%
ROIC N/A
ROA(3y)-1.94%
ROA(5y)4.01%
ROE(3y)-2.5%
ROE(5y)4.98%
ROIC(3y)N/A
ROIC(5y)N/A
MGLD Yearly ROA, ROE, ROICMGLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

MGLD's Gross Margin of 73.44% is fine compared to the rest of the industry. MGLD outperforms 78.08% of its industry peers.
MGLD's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MGLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.44%
GM growth 5Y-0.22%
MGLD Yearly Profit, Operating, Gross MarginsMGLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, MGLD has more shares outstanding
The number of shares outstanding for MGLD has been increased compared to 5 years ago.
The debt/assets ratio for MGLD has been reduced compared to a year ago.
MGLD Yearly Shares OutstandingMGLD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MGLD Yearly Total Debt VS Total AssetsMGLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

MGLD has an Altman-Z score of 5.71. This indicates that MGLD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.71, MGLD belongs to the top of the industry, outperforming 88.58% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that MGLD is not too dependend on debt financing.
MGLD's Debt to Equity ratio of 0.00 is amongst the best of the industry. MGLD outperforms 87.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.71
ROIC/WACCN/A
WACCN/A
MGLD Yearly LT Debt VS Equity VS FCFMGLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

MGLD has a Current Ratio of 4.63. This indicates that MGLD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.63, MGLD belongs to the top of the industry, outperforming 84.47% of the companies in the same industry.
MGLD has a Quick Ratio of 4.22. This indicates that MGLD is financially healthy and has no problem in meeting its short term obligations.
MGLD has a Quick ratio of 4.22. This is amongst the best in the industry. MGLD outperforms 83.56% of its industry peers.
Industry RankSector Rank
Current Ratio 4.63
Quick Ratio 4.22
MGLD Yearly Current Assets VS Current LiabilitesMGLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

MGLD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -449.50%.
Looking at the last year, MGLD shows a decrease in Revenue. The Revenue has decreased by -5.83% in the last year.
MGLD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.03% yearly.
EPS 1Y (TTM)-449.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-658.81%
Revenue 1Y (TTM)-5.83%
Revenue growth 3Y-6.29%
Revenue growth 5Y4.03%
Sales Q2Q%-6.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGLD Yearly Revenue VS EstimatesMGLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MGLD Yearly EPS VS EstimatesMGLD Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MGLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGLD Price Earnings VS Forward Price EarningsMGLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGLD Per share dataMGLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MGLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARYGOLD COMPANIES INC/THE

NYSEARCA:MGLD (2/21/2025, 8:04:02 PM)

0.9722

-0.03 (-2.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-18 2025-02-18
Earnings (Next)05-12 2025-05-12
Inst Owners0.46%
Inst Owner Change-52.91%
Ins Owners7.77%
Ins Owner Change1.14%
Market Cap40.97M
AnalystsN/A
Price TargetN/A
Short Float %1.07%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.25
P/FCF N/A
P/OCF N/A
P/B 1.54
P/tB 1.8
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.78
BVpS0.63
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.37%
ROE -15.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.44%
FCFM N/A
ROA(3y)-1.94%
ROA(5y)4.01%
ROE(3y)-2.5%
ROE(5y)4.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.44%
GM growth 5Y-0.22%
F-Score3
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.23%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.63
Quick Ratio 4.22
Altman-Z 5.71
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)11.17%
Cap/Depr(5y)35.12%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-449.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-658.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.83%
Revenue growth 3Y-6.29%
Revenue growth 5Y4.03%
Sales Q2Q%-6.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-443.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-203.22%
OCF growth 3YN/A
OCF growth 5YN/A